{"id":28371,"date":"2020-09-03T09:02:33","date_gmt":"2020-09-03T09:02:33","guid":{"rendered":"https:\/\/amelie-project.eu\/?page_id=28371"},"modified":"2026-07-01T10:15:54","modified_gmt":"2026-07-01T10:15:54","slug":"vorteile-von-amelie","status":"publish","type":"page","link":"https:\/\/amelie-project.eu\/de\/vorteile-von-amelie\/","title":{"rendered":"Vorteile von AMELIE"},"content":{"rendered":"

[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” disabled_on=”off|off|off” admin_label=”Hero section” _builder_version=”4.16″ background_image=”https:\/\/amelie-project.eu\/wp-content\/uploads\/2020\/10\/AMELIEHEADERBACKGOUND-01-scaled.jpg” background_position=”center_left” custom_margin=”|||” custom_padding=”7%||7%||true|false” custom_padding_tablet=”15%||15%||true|false” custom_padding_phone=”” global_colors_info=”{}”][et_pb_row use_custom_gutter=”on” gutter_width=”1″ custom_padding_last_edited=”on|desktop” _builder_version=”4.16″ _module_preset=”default” width=”100%” module_alignment=”left” custom_padding=”|||4%|false|false” custom_padding_tablet=”|||6%|false|false” custom_padding_phone=”|||7%|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][dsm_block_reveal_text block_reveal_text=”BENEFITS” heading_html_tag=”h1″ block_reveal_color=”#0e94f9″ block_reveal_delay=”0″ _builder_version=”4.16″ _module_preset=”default” header_font=”AMELIE||||||||” header_text_color=”#0e94f9″ header_font_size=”4vw” custom_padding=”||||false|false” custom_padding_tablet=”||||false|false” custom_padding_phone=”||||false|false” custom_padding_last_edited=”on|phone” header_font_size_tablet=”8vw” header_font_size_phone=”10vw” header_font_size_last_edited=”on|desktop” global_colors_info=”{}”][\/dsm_block_reveal_text][dsm_block_reveal_text block_reveal_text=”OF AMELIE” block_reveal_color=”#0e94f9″ _builder_version=”4.16″ _module_preset=”default” header_font=”AMELIE||||||||” header_text_color=”#0e94f9″ header_font_size=”3vw” custom_padding=”||||false|false” custom_padding_tablet=”||||false|false” custom_padding_phone=”||||false|false” custom_padding_last_edited=”on|phone” header_font_size_tablet=”6vw” header_font_size_phone=”7vw” header_font_size_last_edited=”on|desktop” global_colors_info=”{}”][\/dsm_block_reveal_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.16″ transform_scale_tablet=”90%|90%” transform_scale_last_edited=”off|desktop” transform_translate_last_edited=”off|desktop” transform_rotate_last_edited=”off|desktop” transform_skew_last_edited=”off|desktop” transform_origin_last_edited=”off|desktop” transform_styles_last_edited=”off|desktop” custom_margin=”||||false|false” custom_padding=”100px|0px|100px|0px” custom_padding_tablet=”35px|0px|35px|0px|true|false” custom_padding_phone=”15px||15px||true|false” global_colors_info=”{}”][et_pb_row column_structure=”1_3,1_3,1_3″ _builder_version=”4.16″ _module_preset=”default” animation_style=”slide” animation_direction=”bottom” animation_intensity_slide=”11%” global_colors_info=”{}”][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][dsm_tilt_image src=”https:\/\/amelie-project.eu\/wp-content\/uploads\/2020\/09\/science1shadow-4.png” title_text=”science1shadow” dsm_tilt_mobile=”on” dsm_tilt_scale=”1.1″ dsm_tilt_max=”15″ dsm_use_glare=”on” dsm_tilt_glare=”0.5″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/dsm_tilt_image][et_pb_text _builder_version=”4.16″ text_font=”Gotham kinda bold||||||||” text_text_color=”#000000″ text_font_size=”16px” text_line_height=”1.6em” header_font=”Gotham kinda bold|||on|||||” header_text_color=”#000000″ header_font_size=”15px” header_letter_spacing=”1px” header_line_height=”1.4em” header_2_font=”Gotham kinda bold|||on|||||” header_2_text_color=”#000000″ header_2_font_size=”15px” header_2_letter_spacing=”1px” header_2_line_height=”1.4em” header_3_font=”Gotham kinda bold|||on|||||” header_3_text_color=”#000000″ header_3_font_size=”15px” header_3_letter_spacing=”1px” header_3_line_height=”1.4em” header_4_font=”Gotham kinda bold|||on|||||” header_4_text_color=”#000000″ header_4_font_size=”17px” header_4_letter_spacing=”1px” header_4_line_height=”1.4em” header_5_font=”Gotham kinda bold|||on|||||” header_5_text_color=”#000000″ header_5_font_size=”15px” header_5_letter_spacing=”1px” header_5_line_height=”1.4em” header_6_font=”Gotham kinda bold|||on|||||” header_6_text_color=”#000000″ header_6_font_size=”15px” header_6_letter_spacing=”1px” header_6_line_height=”1.4em” text_orientation=”center” max_width=”800px” module_alignment=”center” locked=”off” global_colors_info=”{}”]<\/p>\n

Identifizierung potenzieller neuer regenerativer Therapien f\u00fcr den ungedeckten klinischen Bedarf gro\u00dfer Patientengruppen.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][dsm_tilt_image src=”https:\/\/amelie-project.eu\/wp-content\/uploads\/2020\/09\/science2shadow.png” title_text=”science2shadow” dsm_tilt_mobile=”on” dsm_tilt_scale=”1.1″ dsm_tilt_max=”15″ dsm_use_glare=”on” dsm_tilt_glare=”0.5″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/dsm_tilt_image][et_pb_text _builder_version=”4.16″ text_font=”Gotham kinda bold||||||||” text_text_color=”#000000″ text_font_size=”16px” text_line_height=”1.6em” header_font=”Gotham kinda bold|||on|||||” header_text_color=”#000000″ header_font_size=”15px” header_letter_spacing=”1px” header_line_height=”1.4em” header_2_font=”Gotham kinda bold|||on|||||” header_2_text_color=”#000000″ header_2_font_size=”15px” header_2_letter_spacing=”1px” header_2_line_height=”1.4em” header_3_font=”Gotham kinda bold|||on|||||” header_3_text_color=”#000000″ header_3_font_size=”15px” header_3_letter_spacing=”1px” header_3_line_height=”1.4em” header_4_font=”Gotham kinda bold|||on|||||” header_4_text_color=”#000000″ header_4_font_size=”17px” header_4_letter_spacing=”1px” header_4_line_height=”1.4em” header_5_font=”Gotham kinda bold|||on|||||” header_5_text_color=”#000000″ header_5_font_size=”15px” header_5_letter_spacing=”1px” header_5_line_height=”1.4em” header_6_font=”Gotham kinda bold|||on|||||” header_6_text_color=”#000000″ header_6_font_size=”15px” header_6_letter_spacing=”1px” header_6_line_height=”1.4em” text_orientation=”center” max_width=”800px” module_alignment=”center” locked=”off” global_colors_info=”{}”]<\/p>\n

Die Position Europas in der translationalen regenerativen Medizin wurde gest\u00e4rkt.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][dsm_tilt_image src=”https:\/\/amelie-project.eu\/wp-content\/uploads\/2020\/09\/science3shadow-2.png” title_text=”science3shadow” dsm_tilt_mobile=”on” dsm_tilt_scale=”1.1″ dsm_tilt_max=”15″ dsm_use_glare=”on” dsm_tilt_glare=”0.5″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/dsm_tilt_image][et_pb_text _builder_version=”4.16″ text_font=”Gotham kinda bold||||||||” text_text_color=”#000000″ text_font_size=”16px” text_line_height=”1.6em” header_font=”Gotham kinda bold|||on|||||” header_text_color=”#000000″ header_font_size=”15px” header_letter_spacing=”1px” header_line_height=”1.4em” header_2_font=”Gotham kinda bold|||on|||||” header_2_text_color=”#000000″ header_2_font_size=”15px” header_2_letter_spacing=”1px” header_2_line_height=”1.4em” header_3_font=”Gotham kinda bold|||on|||||” header_3_text_color=”#000000″ header_3_font_size=”15px” header_3_letter_spacing=”1px” header_3_line_height=”1.4em” header_4_font=”Gotham kinda bold|||on|||||” header_4_text_color=”#000000″ header_4_font_size=”17px” header_4_letter_spacing=”1px” header_4_line_height=”1.4em” header_5_font=”Gotham kinda bold|||on|||||” header_5_text_color=”#000000″ header_5_font_size=”15px” header_5_letter_spacing=”1px” header_5_line_height=”1.4em” header_6_font=”Gotham kinda bold|||on|||||” header_6_text_color=”#000000″ header_6_font_size=”15px” header_6_letter_spacing=”1px” header_6_line_height=”1.4em” text_orientation=”center” max_width=”800px” module_alignment=”center” locked=”off” global_colors_info=”{}”]<\/p>\n

Neue Therapien f\u00fcr wichtige Krankheiten und Leiden des Menschen sowie neue Therapieans\u00e4tze, die in der Entwicklungspipeline weiter vorangeschritten sind.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ background_color=”rgba(0,0,0,0.03)” background_position=”top_center” custom_margin=”|||” custom_padding=”100px||100px|” global_colors_info=”{}”][et_pb_row use_custom_gutter=”on” gutter_width=”4″ _builder_version=”4.16″ custom_margin=”||||false|false” custom_padding=”0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” parallax__hover=”off” parallax_method__hover=”on” custom_padding__hover=”|||”][et_pb_blurb title=”Potential new regenerative therapies to address unmet clinical needs of large patient groups identified” url=”#” icon_placement=”left” image_icon_width=”64px” content_max_width=”1400px” admin_label=”Chapter” _builder_version=”4.16″ header_font=”Gotham kinda bold||||||||” header_text_color=”#000000″ header_line_height=”1.5em” body_font=”Gotham kinda bold||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.9em” background_color=”#ffffff” custom_margin=”|||” custom_padding=”30px|40px|30px|40px” animation_style=”zoom” animation_direction=”bottom” animation_intensity_zoom=”20%” animation_starting_opacity=”100%” box_shadow_style=”preset2″ box_shadow_horizontal=”0px” box_shadow_vertical=”0px” box_shadow_blur=”60px” box_shadow_color=”rgba(10,3,3,0.06)” image_max_width=”64px” locked=”off” global_colors_info=”{}”]<\/p>\n

Stuhlinkontinenz ist eine h\u00e4ufige Erkrankung, von der etwa 9% der Erwachsenen in Europa betroffen sind. Diese Zahl d\u00fcrfte jedoch zu niedrig angesetzt sein, da etwa 70% der Betroffenen keinen Arzt aufsuchen. Von denjenigen, die einen Arzt aufsuchen, l\u00e4sst sich nur ein Teil weiter behandeln, und etwa die H\u00e4lfte kommt f\u00fcr die derzeit verf\u00fcgbaren Behandlungsm\u00f6glichkeiten nicht in Frage.<\/div>\n
Der AMELIE-Ansatz bietet gegen\u00fcber bestehenden chirurgischen Eingriffen, die mit Risiken wie Infektionen, Schmerzen sowie Versagen oder Verschiebung des Implantats verbunden sein k\u00f6nnen und manchmal die Anlage eines dauerhaften Stomas erforderlich machen, mehrere Vorteile. Verbesserte Kontinenzergebnisse k\u00f6nnen nicht nur den Patienten zugutekommen, sondern auch den Pflegekr\u00e4ften und den Personen, die auf Wartelisten f\u00fcr Pflegeheime stehen.<\/div>\n
Sollte sich die Behandlung mit implantierbarer Zell-Mikrotr\u00e4ger-Technologie als wirksam erweisen, k\u00f6nnte sie die Lebensqualit\u00e4t der B\u00fcrger in ganz Europa erheblich verbessern. Die Darstellung dieser Therapie als realistische M\u00f6glichkeit zur Wiederherstellung der Kontinenz \u2013 und nicht nur zur Linderung der Symptome \u2013 k\u00f6nnte zudem mehr Patienten dazu ermutigen, \u00e4rztlichen Rat einzuholen, wodurch sich der Zugang zur Behandlung verbessern w\u00fcrde.<\/div>\n

[\/et_pb_blurb][et_pb_blurb title=”Europe\u2019s position in translational regenerative medicine strengthened ” url=”#” icon_placement=”left” image_icon_width=”64px” content_max_width=”1400px” admin_label=”Chapter” _builder_version=”4.16″ header_font=”Gotham kinda bold||||||||” header_text_color=”#000000″ header_line_height=”1.5em” body_font=”Gotham kinda bold||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.9em” background_color=”#ffffff” custom_margin=”|||” custom_padding=”30px|40px|30px|40px” animation_style=”zoom” animation_direction=”bottom” animation_intensity_zoom=”20%” animation_starting_opacity=”100%” box_shadow_style=”preset2″ box_shadow_horizontal=”0px” box_shadow_vertical=”0px” box_shadow_blur=”60px” box_shadow_color=”rgba(10,3,3,0.06)” image_max_width=”64px” locked=”off” global_colors_info=”{}”]<\/p>\n

Europa ist weltweit f\u00fchrend bei zellbasierten Therapien f\u00fcr Patienten mit FI.<\/span> AMELIE st\u00e4rkt nicht nur die dominierende Rolle Europas in diesem Bereich, sondern stellt auch einen Schritt in Richtung Herstellung und Bereitstellung zellbasierter Medizin dar, der es den europ\u00e4ischen B\u00fcrgern erm\u00f6glichen wird, als erste weltweit von einem bahnbrechenden neuen Ansatz der regenerativen Medizin zu profitieren.\u00a0<\/span><\/p>\n

Die Zelltherapie ist ein schnell wachsender Forschungsbereich. Produkte aus der Gewebez\u00fcchtung werden erheblich zunehmen und bieten betr\u00e4chtliche M\u00f6glichkeiten zur St\u00e4rkung der Position Europas in der translationalen regenerativen Medizin. In Europa sind etwa 26% der weltweiten Unternehmen der regenerativen Medizin angesiedelt. Die Entwicklung innovativer Technologien wie implantierbarer TIPS-Mikrocarrier wird Investitionen nach Europa ziehen. AMELIE ist bestrebt, die Wettbewerbsposition der europ\u00e4ischen Unternehmen als Anbieter innovativer Technologien f\u00fcr die regenerative Medizin zu verbessern. Dies wird das Verwertungspotenzial von AMELIE erh\u00f6hen.<\/span><\/p>\n

[\/et_pb_blurb][et_pb_blurb title=”New therapies for major human diseases and conditions, and new approaches for therapy taken further in the development pipeline” url=”#” icon_placement=”left” image_icon_width=”64px” content_max_width=”1400px” admin_label=”Chapter” _builder_version=”4.16″ header_font=”Gotham kinda bold||||||||” header_text_color=”#000000″ header_line_height=”1.5em” body_font=”Gotham kinda bold||||||||” body_text_color=”#000000″ body_font_size=”16px” body_line_height=”1.9em” background_color=”#ffffff” custom_margin=”|||” custom_padding=”30px|40px|30px|40px” animation_style=”zoom” animation_direction=”bottom” animation_intensity_zoom=”20%” animation_starting_opacity=”100%” box_shadow_style=”preset2″ box_shadow_horizontal=”0px” box_shadow_vertical=”0px” box_shadow_blur=”60px” box_shadow_color=”rgba(10,3,3,0.06)” image_max_width=”64px” locked=”off” global_colors_info=”{}”]<\/p>\n

AMELIE ebnet den Weg f\u00fcr identische oder \u00e4hnliche innovative Behandlungen unter Verwendung von ASMDC-Zell-Mikrotr\u00e4ger-Kombinationen f\u00fcr eine Vielzahl anderer klinischer Erkrankungen, die mit dem Verlust der Skelettmuskelfunktion einhergehen, wie Harninkontinenz, Muskeldystrophien und volumetrischer Muskelverlust in Verbindung mit Traumata.\u00a0<\/span><\/p>\n

Das gleiche wissenschaftliche Grundprinzip und der neue Ansatz, die in AMELIE entwickelt wurden, sind auch auf andere verankerungsabh\u00e4ngige Zelltypen anwendbar, die als neue Behandlungsmethoden in der regenerativen Medizin untersucht werden. Neue Produkte, die aus diesen verankerungsabh\u00e4ngigen Zellen bestehen, sollen einige der am st\u00e4rksten beeintr\u00e4chtigenden Krankheiten behandeln, die Muskel-, Knochen-, Knorpel-, Augen-, Herz-\/Kreislauf-, Magen-Darm-\/Leber-, Nieren-, Immun- und Atemwegsgewebe betreffen. Die Einf\u00fchrung der implantierbaren TIPS-Microcarrier-Technologie k\u00f6nnte einen erheblichen Einfluss auf die Ergebnisse haben.<\/span><\/p>\n

In der Zwischenzeit kann das entwickelte Scale-up-Herstellungsverfahren f\u00fcr TIPS-Mikropartikel auf andere Anwendungen der Mikropartikeltechnologie angewendet werden, die derzeit in der Entwicklungspipeline untersucht werden. <\/span><\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t

BENEFITS<\/h1><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t

VON AMELIE<\/h2><\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\"\"<\/span>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Identifizierung potenzieller neuer regenerativer Therapien f\u00fcr den ungedeckten klinischen Bedarf gro\u00dfer Patientengruppen.
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\"\"<\/span>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Die Position Europas in der translationalen regenerativen Medizin wurde gest\u00e4rkt.
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\"\"<\/span>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>New therapies for major human diseases and conditions, and new approaches for therapy taken further in the development pipeline.Faecal incontinence is a common condition affecting approximately 9% of adults in Europe. However, this figure is likely underestimated, as around 70% of individuals do not seek medical advice. Of those who do consult a healthcare professional, only a proportion pursue further treatment, and approximately half are not suitable for currently available options. The AMELIE approach offers several advantages over existing surgical interventions, which can carry risks such as infection, pain, and device failure or dislocation, sometimes resulting in the need for a permanent stoma. Improved continence outcomes have the potential to benefit not only patients, but also carers and […]<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-28371","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/pages\/28371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/comments?post=28371"}],"version-history":[{"count":54,"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/pages\/28371\/revisions"}],"predecessor-version":[{"id":31787,"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/pages\/28371\/revisions\/31787"}],"wp:attachment":[{"href":"https:\/\/amelie-project.eu\/de\/wp-json\/wp\/v2\/media?parent=28371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}